Both in Pharmaceuticals
Enanta Pharmaceuticals vs Indaptus Therapeutics
Over the past year ENTA returned −16.6% and INDP returned −4.7%; their daily moves had a correlation of -0.01.
ENTA −16.6% INDP −4.7%Growth of $1, one year, split-adjusted
| Metric | ENTA | INDP |
|---|---|---|
| Price | $12.64 | $2.85 |
| Market cap | $368.1M | $379.7M |
| Today | +0.20% | −13.37% |
| 1 month | −7.1% | +150.0% |
| 6 months | +3.8% | +60.1% |
| Year to date | −19.8% | −2.1% |
| 1 year | +60.0% | −18.3% |
| Revenue growth (YoY) | −21.6% | — |
| Gross margin | 100.0% | — |
| Net margin | −135.8% | — |
| P/E (TTM) | — | — |
| Price / sales | 5.6× | — |
| Net cash | $189.5M | $11.6M |
| Dividend yield | — | — |
| Volatility (60d) | 41.5% | 193.7% |
| Short % of float | 9.5% | 9.3% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).